SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006871
Filing Date
2019-05-13
Accepted
2019-05-13 12:39:54
Documents
40
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 371171
2 ex31-1.htm EX-31.1 18622
3 ex31-2.htm EX-31.2 19002
4 ex32.htm EX-32 8281
  Complete submission text file 0001493152-19-006871.txt   1565583

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20190331.xml EX-101.INS 137747
6 XBRL SCHEMA FILE pvct-20190331.xsd EX-101.SCH 24629
7 XBRL CALCULATION FILE pvct-20190331_cal.xml EX-101.CAL 34920
8 XBRL DEFINITION FILE pvct-20190331_def.xml EX-101.DEF 62954
9 XBRL LABEL FILE pvct-20190331_lab.xml EX-101.LAB 167102
10 XBRL PRESENTATION FILE pvct-20190331_pre.xml EX-101.PRE 115993
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 19817609
SIC: 2834 Pharmaceutical Preparations